Boise, IDNCT06390345Now EnrollingIRB Ready

Chronic Obstructive Pulmonary Disease Clinical Trial in Boise, ID

Access cutting-edge chronic obstructive pulmonary disease treatment through this clinical trial at a research site in Boise. Study-provided care at no cost to qualified participants.

Sponsored by Seattle Institute for Biomedical and Clinical Research

Quick Self-Assessment

See if you qualify for this Boise location

Preparing your pre-screening questions…

Expert Care in Boise

Access chronic obstructive pulmonary disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic obstructive pulmonary disease treatment provided free

Apply for This Boise Location

Check if you qualify for this chronic obstructive pulmonary disease clinical trial in Boise, ID

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boise

    Convenient for ID residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boise site if eligible
  4. 4Begin participation

About This Chronic Obstructive Pulmonary Disease Study in Boise

The investigators will conduct a Type I hybrid effectiveness-implementation study to test an integrated telehealth intervention among 400 overweight and obese patients with Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA). The investigators will include eligible participants receiving primary care at one of five Department of Veterans Affairs (VA) medical centers and their community-based outpatient clinics. The investigators will randomize patients in a 1:1 ratio to the multi-component intervention or "enhanced" usual care, stratifying by age (≥65 vs. \< 65) and site. Participants randomized to the intervention will receive an integrated, telehealth-delivered intervention composed of a self-directed lifestyle program and supervised pulmonary rehabilitation. At the end of 3 months, the investigators will offer to enter a recommendation for weight management medications on behalf of eligible intervention participants. In the post-core period (months 4-12), participants will continue to have as-needed access to the lifestyle coach. For participants randomized to the "enhanced" usual care group, study staff will prompt the patient's primary care provider to refer them to existing weight loss management and pulmonary rehabilitation programs. Follow-up will occur at virtual visits at 3 and 12 months. The primary effectiveness outcome at 1-year is quality of life measured by the SF-12 Physical Component Summary Score. Secondary effectiveness outcomes will include other measures of quality of life (including sleep related impairment), sleep disturbance, disease severity (COPD exacerbations and respiratory event index for OSA), depression, social support, weight loss and cardiovascular risk. In addition to assessing effectiveness, investigators will also conduct a concurrent implementation process evaluation using the RE-AIM framework.

Sponsor: Seattle Institute for Biomedical and Clinical Research

Who Can Participate

Inclusion Criteria

COPD: Defined by presence of airflow obstruction (FEV1/FVC \< 0.70) on post-bronchodilator spirometry
≥10 pack year history of tobacco use
Self-reported clinician diagnosis of OSA (or presence of OSA on research HSAT)
BMI ≥ 25 kg/m2
Symptoms of dyspnea defined by MMRC score of ≥1

Exclusion Criteria

Self-report of weight change \>15 lbs. during prior 3 months
Current active weight loss treatment, including: 1) research-based commercial weight loss programs (e.g., Weight Watchers, Jenny Craig, HMR, Omada, TOPS, MOVE!); 2) other weight loss or related behavioral health or wellness programs led by trained personnel (professional or lay) in the local community; 3) prescription weight loss medication within last 3 months; and scheduled bariatric surgery.
Severe illness from any cause
Diagnosis of bulimia or history of purging behavior
Active enrollment in pulmonary rehabilitation
Safety and/or adherence concerns due to severe physical or mental health issues or life expectancy \< 12 months. These include but may not be limited to: unstable cardiac arrhythmias, active or recent (within one month) myocardial infarction, active or recent (within one month) COPD exacerbation, angina not well-controlled with medication, significant musculoskeletal comorbidities or physical infirmities that preclude participation in an exercise program, and the need for supplemental oxygen ≥ 5 lpm at rest or with exertion.
Pregnant, lactating, or planning to become pregnant during the study period
Participation in other intervention studies.
Unable to complete surveys in English

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boise?

Yes, this clinical trial (NCT06390345) has an active research site in Boise, ID that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Obstructive Pulmonary Disease Treatment Options in Boise, ID

If you're searching for chronic obstructive pulmonary disease treatment options in Boise, ID, this clinical trial (NCT06390345) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boise research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic obstructive pulmonary disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic obstructive pulmonary disease clinical trials near you to find additional studies recruiting in your area.

More Ulcerative Colitis Trials in Boise, ID

See all ulcerative colitis clinical trials recruiting in Boise — not just this study.

Browse Ulcerative Colitis Trials in Boise

Ready to Join in Boise?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boise, ID